JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2014, Vol. 52 ›› Issue (11): 6-10.doi: 10.6040/j.issn.1671-7554.0.2014.429

Previous Articles     Next Articles

Luteolin activates Nrf2 signalling pathway and confers protection against H2O2-induced toxicity in EA.hy926 cells

CHEN Hongzhong1, LI Haizhen2, REN Dongmei2   

  1. 1. Center for Drug Evaluation & Certification, Shandong Food and Drug Administration, Jinan 250013, Shandong, China;
    2. Key Lab of Chemical Biology Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, Shandong, China
  • Received:2014-06-30 Published:2014-11-10

Abstract: Objective To investigate the effect of luteolin on nuclear factor erythroid-2 related factor 2 (Nrf2) signalling pathway, and evaluate the protection on H2O2-induced toxicity in human umbilical vein EA.hy926 cells. Methods Cells were divided into control, positive drug (sulforaphane) treated, H2O2 treated, luteolin with different concentrations (5,10,20,40 μmol/L) treated, and luteolin with different concentrations (5,10,20,40 μmol/L) and H2O2 cotreated groups. ARE luciferase reporter gene assay, Western blotting analysis and qRT-PCR assay were used for identification of luteolin on activiting Nrf2 signalling pathway; flow cytometry with a fluorescent probe uploading was adopted for detecting the intracellular reactive oxygen species (ROS) levels; MTT assay was carried out for evaluating the protection against H2O2-induced toxicity. Results Luteolin increased the luciferase activity dose-dependently, enhanced both the protein and mRNA levels of Nrf2 and its downstream gene heme oxygenase-1 (HO-1), quinone reductase enzyme NAD(P)H: quinone oxidoreductase 1 (NQO1) and glutamate cysteine ligase modifier subunit (GCLM), and decreased intracellular ROS levels. Co-treatment with luteolin improved cell survival compared with H2O2 treatment alone. Conclusion Luteolin activates Nrf2 signalling pathway in EA.hy926 cells, inhibits H2O2-induced cytotoxicity and confers protection against oxidative-induced injury in EA.hy926 cells.

Key words: nuclear factor erythroid-2 related factor 2 signalling pathway, EA.hy926 cells, Luteolin, H2O2

CLC Number: 

  • R965.1
[1] Moi P, Chan K, Asunis I, et al. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region[J]. Proc Natl Acad Sci U S A, 1994, 91(21):9926-9930.
[2] Chan K, Han X D, Kan Y W. An important function of Nrf2 in combating oxidative stress:detoxification of acetaminophen[J]. Proc Natl Acad Sci U S A, 2001, 98(8):4611-4616.
[3] Ishii T, Itohk K, Takahashi S, et al. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages[J]. J Biol Chem, 2000, 275(21):16023-16029.
[4] Haunstetter A, Izumo S. Apoptosis:basic mechanisms and implications for cardiovascular disease[J]. Circ Res, 1998, 82(11):1111-1129.
[5] Lubrano V, Balzan S. LOX-1 and ROS, inseparable factors in the process of endothelial damage[J]. Free Radic Res, 2014, 48(8):841-848.
[6] Zrelli H, Matsuoka M, Kitazaki S, et al. Hydroxytyrosol induces proliferation and cytoprotection against oxidative injury in vascular endothelial cells: role of Nrf2 activation and HO-1 induction[J]. J Agric Food Chem, 2011, 59(9):4473-4482.
[7] Dreger H, Westphal K, Wilck N, et al. Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2[J]. Cardiovasc Res, 2010, 85(2):395-403.
[8] Strisciuglio T, De Luca S, Capuano E, et al. Endothelial dysfunction: its clinical value and methods of assessment[J]. Curr Atheroscler Rep, 2014, 16(6):417.
[9] Itoh K, Ishii T, Wakabayashi N, et al. Regulatory mechanisms of cellular response to oxidative stress[J]. Free Radic Res, 1999, 31(4):319-324.
[10] Zhang D D, Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress[J]. Mol Cell Biol, 2003, 23(22):8137-8151.
[11] Liu H, Talalay P. Relevance of anti-inflammatory and antioxidant activities of exemestane and synergism with sulforaphane for disease prevention[J]. Proc Natl Acad Sci U S A, 2013, 110(47):19065-19070.
[12] Fahey J W, Haristoy X, Dolan P M, et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors[J]. Proc Natl Acad Sci U S A, 2002, 99(11):7610-7615.
[13] Seelinger G, Merfort I, Schempp C M. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin[J]. Planta Med, 2008, 74(14):1667-1677.
[14] Xu J, Wang H, Ding K, et al. Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE pathway[J]. Free Radic Biol Med, 2014, 71:186-195.
[15] Tan X, Jin P, Feng L, et al. Protective effect of luteolin on cigarette smoke extract-induced cellular toxicity and apoptosis in normal human bronchial epithelial cells via the Nrf2 pathway[J]. Oncol Rep, 2014, 31(4):1855-1862.
[16] 徐统震,孙雪飞,任冬梅,等. 木犀草素抑制肺癌细胞A549的增殖及其联合化疗作用[J]. 山东大学学报:医学版, 2012, 50(7):50-54. XU Tongzhen, SUN Xuefei, REN Dongmei, et al. Anti-proliferation activity of luteolin and its role in combined chemotherapy on lung cancer A549 cells[J]. Journal of Shandong University:Health Sciecnces, 2012, 50(7):50-54.
[1] ZHAO Canbin, SHAO Jiang, GUAN Donghui, QIN Ying, DING Qiang, GUO Liang, WANG Weiwei, CHEN Wei, YAN Xiaolong, ZENG Ping. Mechanism of luteolin regulating Wnt/β-catenin signal pathway in inflammatory microenvironment to promote chondrogenic differentiation of bone marrow mesenchymal stem cells [J]. Journal of Shandong University (Health Sciences), 2025, 63(7): 11-22.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!